Carlos Gallardo Piqué

Venture Partner at Ysios Capital Partners SGEIC SA

Carlos Gallardo Piqué

Carlos Gallardo Piqué

Venture Partner at Ysios Capital Partners SGEIC SA

Overview
RelSci Relationships

43

Number of Boards

1

Relationships
RelSci Relationships are individuals Carlos Gallardo Piqué likely has professional access to. A relationship does not necessarily indicate a personal connection.

Corporate Director & General Counsel at Almirall SA

Relationship likelihood: Strong

Chief Executive Officer at Almirall SA

Relationship likelihood: Strong

Venture Partner at Ysios Capital Partners SGEIC SA

Relationship likelihood: Strong

Executive Vice President Finance & Chief Financial Officer at Almirall SA

Relationship likelihood: Strong

Executive Vice President R&D & Chief Scientific Officer at Almirall SA

Relationship likelihood: Strong

Administrator at Almirall-Produtos Farmaceuticos Lda.

Relationship likelihood: Strong

Former Partner at Booz Allen Hamilton, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at AstraZeneca Plc

Relationship likelihood: Strong

Former Partner at Prodes SA

Relationship likelihood: Strong

Former Chairman & Chief Executive Officer at Almirall SA

Relationship likelihood: Strong

Paths to Carlos Gallardo Piqué
Potential Connections via
Relationship Science
You
Carlos Gallardo Piqué
Venture Partner at Ysios Capital Partners SGEIC SA
Education

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Career History
Venture Partner
2014 - Current

Ysios is an active manager which invests in early- and mid-stage human healthcare and biotechnology companies, focusing on product development in the biotechnology, emerging pharmaceuticals, healthcare and medical technology sectors. They rarely invest in services and their geographic focus is on Spain although they also selectively invest outside Spain.The firm seeks to invest from EUR 0.5-4 million in companies with a cohesive management team with a track record, attractive market potential, a platform technology capable of generating new product candidates on a sustainable basis, a competitive advantage, clearly outlined milestones to be achieved in two to three years, strong entry barriers and a clear and realistic exit path. They reserve additional capital for follow-up investments.In Spain, Ysios typically acts as lead or co-lead investor, always syndicating with other venture capital firms. For larger transactions, especially in circumstances where they can leverage their national networks, they seek to invest in international syndicates with other dedicated life sciences and healthcare investors.The firm generally exits investments via IPOs or M&A within four to six years.

Managing Director
2008 - 2013

Almirall Ltd. is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain.In Almirall they research, develop, produce and market proprietary R&D medicines and those under licence with the aim of improving people's health and wellbeing.They devote big human and economic resources to constant research into new drugs and to obtaining effective and safe products against discomfort and disease.

Boards & Committees
External Director
2014 - Current

Almirall SA engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The company operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological and gastrointestinal diseases. The company was founded in 1943 and is headquartered in Barcelona, Spain.

Other Affiliations

Carlos Gallardo Piqué is affiliated with Ysios Capital Partners SGEIC SA, Almirall Ltd., Almirall SA